Linked Life Data

18957682

Source:http://linkedlifedata.com/resource/pubmed/id/18957682

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
2008-11-5
pubmed:abstractText
Recent data suggest that statin use may be associated with a reduced risk of advanced prostate cancer. However, the influence of statins on prostate-specific antigen (PSA) levels and what effect this could potentially have on prostate cancer diagnosis are unknown.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Monounsaturated, http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Lovastatin, http://linkedlifedata.com/resource/pubmed/chemical/Pravastatin, http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin, http://linkedlifedata.com/resource/pubmed/chemical/fluvastatin
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1460-2105
pubmed:author
pubmed:issnType
Electronic
pubmed:day
5
pubmed:volume
100
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1511-8
pubmed:dateRevised
2009-4-16
pubmed:meshHeading
pubmed-meshheading:18957682-Aged, pubmed-meshheading:18957682-Cholesterol, HDL, pubmed-meshheading:18957682-Cholesterol, LDL, pubmed-meshheading:18957682-Early Diagnosis, pubmed-meshheading:18957682-Fatty Acids, Monounsaturated, pubmed-meshheading:18957682-Heptanoic Acids, pubmed-meshheading:18957682-Humans, pubmed-meshheading:18957682-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:18957682-Incidence, pubmed-meshheading:18957682-Indoles, pubmed-meshheading:18957682-Linear Models, pubmed-meshheading:18957682-Longitudinal Studies, pubmed-meshheading:18957682-Lovastatin, pubmed-meshheading:18957682-Male, pubmed-meshheading:18957682-Middle Aged, pubmed-meshheading:18957682-Multivariate Analysis, pubmed-meshheading:18957682-Pravastatin, pubmed-meshheading:18957682-Prostate-Specific Antigen, pubmed-meshheading:18957682-Prostatic Neoplasms, pubmed-meshheading:18957682-Pyrroles, pubmed-meshheading:18957682-Risk Assessment, pubmed-meshheading:18957682-Simvastatin, pubmed-meshheading:18957682-Tumor Markers, Biological, pubmed-meshheading:18957682-Veterans
pubmed:year
2008
pubmed:articleTitle
The influence of statin medications on prostate-specific antigen levels.
pubmed:affiliation
Division of Urologic Surgery, Department of Surgery, and the Duke Prostate Center, Duke University School of Medicine, Durham, NC 27710, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't